Publications by authors named "Roberto Murialdo"

Claim this Profile
A
A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.
Carolina Sciortino, Federico Nichetti, Francesca Bergamo, Federica Palermo, Stefano Tamberi, Roberto Murialdo

Dig Liver Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center.
Alberto Puccini, Simone Nardin, Lucia Trevisan, Sonia Lastraioli, Viviana Gismondi, Roberto Murialdo

Eur J Cancer Prev· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Geriatric Comanagement in Older Patients Undergoing Surgery for Gastrointestinal Cancer: A Retrospective, Before-and-After Study.
Chiara Giannotti, Andrea Massobrio, Luca Carmisciano, Alessio Signori, Armando Napolitano, Roberto Murialdo

J Am Med Dir Assoc· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Alessandra Raimondi, Giovanni Randon, Michele Prisciandaro, Filippo Pagani, Sara Lonardi, Roberto Murialdo

Int J Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Multidisciplinary Approach of Rectal Cancer: The Experience of "COMRE Group" Model.
Stefano Scabini, Emanuele Romairone, Davide Pertile, Andrea Massobrio, Alessandra Aprile, Roberto Murialdo

Diagnostics (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study.
Francesco Ravera, Roberto Borea, Gabriella Cirmena, Martina Dameri, Lorenzo Ferrando, Roberto Murialdo

J Transl Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.
Paolo Manca, Salvatore Corallo, Sara Lonardi, Giovanni Fucà, Adele Busico, Roberto Murialdo

Br J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.
Giovanni Fucà, Alessandra Raimondi, Michele Prisciandaro, Sara Lonardi, Chiara Cremolini, Roberto Murialdo

Oncologist· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer.
Giacomo Tini, Pietro Ameri, Giulia Buzzatti, Matteo Sarocchi, Roberto Murialdo

Front Cardiovasc Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program.
Giacomo Tini, Matteo Sarocchi, Davide Sirello, Roberto Murialdo, Giuseppe Fornarini

Eur J Prev Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment.
Francesca Valdemarin, Irene Caffa, Angelica Persia, Anna Laura Cremonini, Lorenzo Ferrando, Roberto Murialdo

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Alessandra Raimondi, Salvatore Corallo, Sara Lonardi, Carlotta Antoniotti, Lorenza Rimassa, Roberto Murialdo

Support Care Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study.
Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Roberto Murialdo

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Added Value of Baseline Circulating Tumor DNA Profiling in Patients with Molecularly Hyperselected, Left-sided Metastatic Colorectal Cancer.
Paolo Manca, Salvatore Corallo, Adele Busico, Sara Lonardi, Francesca Corti, Roberto Murialdo

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer.
Paolo Manca, Salvatore Corallo, Giovanni Randon, Sara Lonardi, Chiara Cremolini, Roberto Murialdo

Eur J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, Federica Morano, Roberto Moretto, Roberto Murialdo

Br J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.
Alessandra Raimondi, Massimo Di Maio, Federica Morano, Salvatore Corallo, Sara Lonardi, Roberto Murialdo

Eur J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a predictor of one-year mortality in older patients with cancer by geriatric and oncologic parameters.
Chiara Giannotti, Gabriele Zoppoli, Lorenzo Ferrando, Roberto Murialdo, Irene Caffa

J Geriatr Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.
Lorenzo Ferrando, Gabriella Cirmena, Anna Garuti, Stefano Scabini, Federica Grillo, Roberto Murialdo

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches.
Paolo Bossi, Mario Airoldi, Maria Antonietta Aloe Spiriti, Andrea Antonuzzo, Giorgio Bonciarelli, Roberto Murialdo

Expert Opin Drug Saf· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.
Matteo Bauckneht, Selene Capitanio, Maria Isabella Donegani, Elisa Zanardi, Alberto Miceli, Roberto Murialdo

Cancers (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative Hyperselection of Patients With and Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy.
Federica Morano, Salvatore Corallo, Sara Lonardi, Alessandra Raimondi, Chiara Cremolini, Roberto Murialdo

J Clin Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status.
Chiara Giannotti, Silvia Sambuceti, Alessio Signori, Alberto Ballestrero, Roberto Murialdo

J Geriatr Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Filippo Pietrantonio, Federica Morano, Salvatore Corallo, Rosalba Miceli, Sara Lonardi, Roberto Murialdo

JAMA Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.
Edoardo Isnaldi, Anna Garuti, Gabriella Cirmena, Stefano Scabini, Edoardo Rimini, Roberto Murialdo

J Transl Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis